Haemonetics CorporationHAENYSE
Loading
EV to Sales HistoryFair Value
Percentile Rank50
3Y CAGR-7.2%
5Y CAGR-11.1%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-7.2%/yr
vs -3.5%/yr prior
5Y CAGR
-11.1%/yr
Recent acceleration
Acceleration
-3.8pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineFair Value
PeriodValueYoY Change
20253.01-20.0%
20243.76-6.1%
20234.01+6.2%
20223.77-47.1%
20217.14+31.7%
20205.42+9.1%
20194.97+14.2%
20184.35+70.2%
20172.56+12.0%
20162.28-